인유두종바이러스 관련 질환의 예방을 위한 남성 대상 백신의 임상적 유용성

• 영문명: Clinical Benefit of Vaccinating Male Against HPV-related Diseas
• 발행기관: 대한두경부종양학회
• 저자명: 이세영(Sei Young Lee)
• 간행물 정보: 『대한두경부종양학회지』대한두경부종양학회지 제38권 제1호, 11~16쪽, 전체 6쪽
• 주제분류: 의약학 > 종양학
• 파일형태: PDF
• 발행일자: 2022.05.30

영문 초록

HHPV (Human Papillomavirus) is a DNA virus that can cause benign lesions, genitourinary cancer, and oropharyngeal cancer by penetrating the mucous membrane and skin. It is widely known to be transmitted mainly through sexual contact. As with many viral infections, vaccines have been developed to prevent infection with HPV. Currently, in many countries, HPV vaccines are mainly used for national immunization for women to prevent diseases that traditionally occur frequently in women, especially cervical cancer. However, since the vaccination rate is relatively low, many countries are struggling with ways to increase the vaccination rate. Meanwhile, the incidence of oropharyngeal cancer caused by HPV in men has been increasing recently. In the United States, the annual number of oropharyngeal cancers in men already exceeds the number of cervical cancers in women, so HPV infection in men has emerged as a major problem. Accordingly, interest in HPV vaccination in men has also increased, and studies on the effectiveness and necessity of vaccination of both women and men compared to women alone are being actively conducted. In this paper, the evidence of HPV vaccination for men will be reviewed through previous studies, and its validity and cost-effectiveness will be analyzed to bolster the clinical usefulness of HPV vaccination for men.

목차

서론

HPV 백신 현황

HPV의 집단면역

남성 질환에서 HPV 백신의 역할

HPV 감염과 구인두암

구인두암의 선별검사

남성 대상 HPV 백신 접종의 암 예방 추가 효과

남성 대상 HPV 백신의 비용 효과성

결론

References

키워드

HPV Vaccine Prevention Oropharyngeal cancer